Temozolomide, (tmz) is an oral chemotherapy drug. it is an alkylating agent used as a treatment of some brain cancers- as a second-line treatment for astrocytoma and a first-line treatment for glioblastoma multiforme.indications* nitrosourea- and procarbazine-refractory anaplastic astrocytoma.* newly diagnosed glioblastoma multiforme
Voir plus de détails